This message was sent to ##Email##
|
|
|
|
|
Healio
Data indicate that fewer medical students and fellows are joining the HIV workforce, perhaps under the impression that HIV is no longer the exciting and rewarding field it once was. Healio asked Infectious Disease News Editorial Board member Dr. Peter Chin-Hong, professor of medicine and director of the transplant infectious disease program at University of California, San Francisco, what the “new HIV” is — the ID-related field that is attracting today’s young clinicians.
READ MORE
CIDRAP
A Chinese health official said today that 14 healthcare workers have been infected with the Wuhan-linked novel coronavirus (2019-nCoV), bolstering evidence of human-to-human spread and spurring new questions about virus circulation against a backdrop of other winter respiratory illnesses.
READ MORE
|
Promoted by
|
|
|
|
 |
Infection Control Today
Premature babies and the neonatal intensive care units where they often require care, are uniquely susceptible to infectious disease threats, making infection prevention efforts vital. The Centers for Disease Control and Prevention reported that in 2018, one in 10 babies were born early in the U.S.
READ MORE
Dark Daily
Medical laboratory testing has long been the key element in hospitals’ fight to reduce deaths caused by sepsis, a complication caused by the human body’s response to infection which can injure organs and turn fatal. But clinical laboratory testing takes time, particularly if infectious agents must be cultured in the microbiology lab. And sepsis acts so quickly, by the time the condition is diagnosed it is often too late to prevent the patient’s death.
READ MORE
 |
|
The miniiSED™ is the newest addition to the iSED™ family of ESR analyzers from ALCOR Scientific. The miniiSED™ is a single position, fully automated ESR analyzer that works directly from the primary EDTA tube and produces an ESR result in just 15 seconds. The miniiSED™ is the ideal ESR analyzer for small laboratories, POL’s and emergency clinics.
|
|
Garvan Institute of Medical Research via ScienceDaily
Epigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatment for ER+ breast cancer, which accounts for 70% of all diagnoses.
Reversing these changes, researchers say, has significant potential to help reduce breast cancer relapse.
READ MORE
|
|
Medical News Today
A group of researchers has brought the idea of food as a medicine one step closer. They have identified certain common foodstuffs that alter our microbiome.
READ MORE
Advertisement
|
|
CIDRAP
Some key indicators that track U.S. flu activity declined a bit, but remain high, and influenza B continues to slightly predominate the 2019-20 flu season, the Centers for Disease Control and Prevention said in its weekly FluView update. Hospitalization and death rates are not high at this point in the season, the CDC said as it reported data through Jan. 11, but it confirmed seven new flu-related deaths in children.
READ MORE
Infection Control Today
Now that the planet’s attention is turned toward infectious disease thanks to the spotting of coronavirus in the United States, the World Health Organization took the opportunity to point to another problem: the growing shortage of antibiotics available to fight all pathogens.
A WHO press release calls attention to two recent studies that the organization conducted: "2019 Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline," and its companion publication: "Antibacterial Agents in Preclinical Development."
READ MORE
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests.
Learn more
|
|
|
|
MedPage Today
Outcomes have improved over the last quarter-century for patients undergoing allogeneic hematopoietic cell transplantation for treating their cancer, a single-center cohort study indicated.
Reported in the Annals of Internal Medicine, an adjusted analysis revealed that patients who had a transplant from 2013-2017 had a 34% lower risk of dying within 200 days after transplantation from a cause unrelated to disease relapse compared with patients who had a transplant from 2003-2007.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
